- Home
- APPN vs IRON Comparison
APPN vs IRON Comparison
Compare APPN & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APPN
- IRON
- Stock Information
- Founded
- APPN 1999
- IRON 2017
- Country
- APPN United States
- IRON United States
- Employees
- APPN N/A
- IRON N/A
- Industry
- APPN Computer Software: Prepackaged Software
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- APPN Technology
- IRON Health Care
- Exchange
- APPN Nasdaq
- IRON Nasdaq
- Market Cap
- APPN 2.0B
- IRON 2.0B
- IPO Year
- APPN 2017
- IRON N/A
- Fundamental
- Price
- APPN $29.11
- IRON $59.41
- Analyst Decision
- APPN Hold
- IRON Strong Buy
- Analyst Count
- APPN 6
- IRON 11
- Target Price
- APPN $34.40
- IRON $95.73
- AVG Volume (30 Days)
- APPN 1.2M
- IRON 326.6K
- Earning Date
- APPN 08-07-2025
- IRON 08-07-2025
- Dividend Yield
- APPN N/A
- IRON N/A
- EPS Growth
- APPN N/A
- IRON N/A
- EPS
- APPN N/A
- IRON N/A
- Revenue
- APPN $657,803,000.00
- IRON N/A
- Revenue This Year
- APPN $12.72
- IRON N/A
- Revenue Next Year
- APPN $10.04
- IRON N/A
- P/E Ratio
- APPN N/A
- IRON N/A
- Revenue Growth
- APPN 13.67
- IRON N/A
- 52 Week Low
- APPN $24.00
- IRON $30.82
- 52 Week High
- APPN $43.33
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- APPN 49.62
- IRON 53.03
- Support Level
- APPN $28.31
- IRON $57.54
- Resistance Level
- APPN $30.15
- IRON $61.05
- Average True Range (ATR)
- APPN 1.26
- IRON 2.10
- MACD
- APPN 0.11
- IRON -0.19
- Stochastic Oscillator
- APPN 42.33
- IRON 35.40
About APPN Appian Corporation
Appian Corp is a low-code enterprise platform-as-a-service company focusing on business process management. The company's Appian platform is an integrated automation platform providing tools for organizations to design, automate, and optimize end-to-end processes and complex business operations. Capabilities include case management, robotic process automation, artificial intelligence, data fabric, and process mining. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based with the remainder from services, with much of its subscription revenue being derived from its cloud-based platform. Geographically, the company derives maximum revenue from its business in the United States.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.